Background: Asthma guidelines emphasize maintaining disease control. Howeve
r, objective measures of asthma disease control are lacking. Objective: We
sought to examine the relationship between exhaled nitric oxide (NO) levels
and measures of asthma disease control versus asthma disease severity.
Methods: We performed a cross-sectional study of 100 patients (age range, 7
-80 years) with asthma. We administered a questionnaire to identify charact
eristics of asthma, performed spirometric testing before and after administ
ration of a bronchodilator, and measured exhaled NO levels in all participa
nts.
Results: Exhaled NO was significantly correlated with the Following markers
of asthma disease control: asthma symptoms within the past 2 weeks (P = .0
2), dyspnea score (P = .02), daily use of rescue medications (P = .01), and
reversibility of airflow obstruction (P = .02), Exhaled NO levels were not
correlated with the following markers of asthma disease severity: history
of respiratory failure (P = .20), health care use (P = .08), fixed airflow
obstruction (P = .91), or a validated asthma severity score (P = .19), Mark
ers with relevance to both disease control and severity showed either a wea
k correlation (FEV1 and FEV1 percent predicted) or no correlation (controll
er drug use) with exhaled NO,
Conclusion: We conclude that exhaled NO levels are correlated predominantly
with markers of asthma control rather than asthma severity. Monitoring of
exhaled NO may be useful in outpatient asthma management.